Timken Reports First-Quarter 2025 Results
Timken reported Q1 2025 financial results with sales of $1.14 billion, down 4.2% year-over-year. The company's net income was $78.3 million, with diluted EPS of $1.11 and adjusted EPS of $1.40.
Key highlights:
- Net income margin decreased to 6.9% from 8.7% last year
- Adjusted EBITDA margin fell to 18.2% from 20.7%
- Free cash flow improved to $23.4 million
- Returned $48.2 million to shareholders through dividends and share repurchases
The company updated its 2025 outlook due to tariff impacts, now expecting:
- Full-year EPS range of $3.90-$4.40
- Adjusted EPS of $5.10-$5.60
- Revenue growth between -2.5% to 0% compared to 2024
- Cost reduction target of $75 million in savings
Timken ha comunicato i risultati finanziari del primo trimestre 2025 con vendite pari a 1,14 miliardi di dollari, in calo del 4,2% rispetto allo stesso periodo dell'anno precedente. L'utile netto della società è stato di 78,3 milioni di dollari, con un utile per azione diluito di 1,11 dollari e un utile per azione rettificato di 1,40 dollari.
Punti salienti:
- Il margine di utile netto è sceso al 6,9% dal 8,7% dell'anno scorso
- Il margine EBITDA rettificato è diminuito al 18,2% dal 20,7%
- Il flusso di cassa libero è migliorato a 23,4 milioni di dollari
- Restituiti 48,2 milioni di dollari agli azionisti tramite dividendi e riacquisto di azioni
La società ha aggiornato le previsioni per il 2025 a causa dell'impatto dei dazi, ora prevedendo:
- Un intervallo di utile per azione annuale tra 3,90 e 4,40 dollari
- Un utile per azione rettificato tra 5,10 e 5,60 dollari
- Una crescita dei ricavi compresa tra -2,5% e 0% rispetto al 2024
- Un obiettivo di riduzione dei costi pari a 75 milioni di dollari di risparmi
Timken reportó resultados financieros del primer trimestre de 2025 con ventas de 1,14 mil millones de dólares, una disminución del 4,2% interanual. La utilidad neta de la compañía fue de 78,3 millones de dólares, con una utilidad por acción diluida de 1,11 dólares y una utilidad ajustada por acción de 1,40 dólares.
Puntos clave:
- El margen de utilidad neta disminuyó al 6,9% desde el 8,7% del año pasado
- El margen EBITDA ajustado cayó al 18,2% desde el 20,7%
- El flujo de caja libre mejoró a 23,4 millones de dólares
- Se devolvieron 48,2 millones de dólares a los accionistas mediante dividendos y recompras de acciones
La compañía actualizó sus perspectivas para 2025 debido a los impactos arancelarios, ahora esperando:
- Un rango de utilidad por acción para todo el año de 3,90 a 4,40 dólares
- Una utilidad ajustada por acción de 5,10 a 5,60 dólares
- Un crecimiento de ingresos entre -2,5% y 0% en comparación con 2024
- Un objetivo de reducción de costos de 75 millones de dólares en ahorros
팀켄은 2025년 1분기 재무실적을 발표했으며 매출은 11억 4천만 달러로 전년 동기 대비 4.2% 감소했습니다. 회사의 순이익은 7,830만 달러였으며 희석 주당순이익(EPS)은 1.11달러, 조정 EPS는 1.40달러였습니다.
주요 내용:
- 순이익률은 지난해 8.7%에서 6.9%로 하락
- 조정 EBITDA 마진은 20.7%에서 18.2%로 감소
- 자유 현금 흐름은 2,340만 달러로 개선
- 배당금과 자사주 매입을 통해 주주에게 4,820만 달러 반환
관세 영향으로 인해 2025년 전망을 업데이트하며, 현재 예상치는 다음과 같습니다:
- 연간 주당순이익 범위 3.90~4.40달러
- 조정 주당순이익 5.10~5.60달러
- 2024년 대비 매출 성장률 -2.5%에서 0% 사이
- 7,500만 달러 비용 절감 목표
Timken a publié ses résultats financiers du premier trimestre 2025 avec un chiffre d'affaires de 1,14 milliard de dollars, en baisse de 4,2 % par rapport à l'année précédente. Le bénéfice net de l'entreprise s'est élevé à 78,3 millions de dollars, avec un BPA dilué de 1,11 dollar et un BPA ajusté de 1,40 dollar.
Points clés :
- La marge bénéficiaire nette a diminué à 6,9 % contre 8,7 % l'an dernier
- La marge EBITDA ajustée est passée de 20,7 % à 18,2 %
- Le flux de trésorerie disponible s'est amélioré à 23,4 millions de dollars
- 48,2 millions de dollars ont été reversés aux actionnaires via dividendes et rachats d'actions
La société a mis à jour ses prévisions pour 2025 en raison des impacts tarifaires, s'attendant désormais à :
- Une fourchette de BPA annuelle de 3,90 à 4,40 dollars
- Un BPA ajusté entre 5,10 et 5,60 dollars
- Une croissance du chiffre d'affaires comprise entre -2,5 % et 0 % par rapport à 2024
- Un objectif de réduction des coûts de 75 millions de dollars d'économies
Timken meldete die Finanzergebnisse für das erste Quartal 2025 mit einem Umsatz von 1,14 Milliarden US-Dollar, was einem Rückgang von 4,2 % im Jahresvergleich entspricht. Der Nettogewinn des Unternehmens betrug 78,3 Millionen US-Dollar, mit einem verwässerten Gewinn je Aktie (EPS) von 1,11 US-Dollar und einem bereinigten EPS von 1,40 US-Dollar.
Wichtige Highlights:
- Die Nettogewinnmarge sank von 8,7 % im Vorjahr auf 6,9 %
- Die bereinigte EBITDA-Marge fiel von 20,7 % auf 18,2 %
- Der freie Cashflow verbesserte sich auf 23,4 Millionen US-Dollar
- Es wurden 48,2 Millionen US-Dollar an Aktionäre durch Dividenden und Aktienrückkäufe zurückgeführt
Das Unternehmen hat aufgrund der Auswirkungen von Zöllen seine Prognose für 2025 aktualisiert und erwartet nun:
- Eine Jahres-EPS-Spanne von 3,90 bis 4,40 US-Dollar
- Ein bereinigtes EPS von 5,10 bis 5,60 US-Dollar
- Ein Umsatzwachstum zwischen -2,5 % und 0 % im Vergleich zu 2024
- Ein Kostensenkungsziel von 75 Millionen US-Dollar Einsparungen
- Solid cash flow performance with net cash from operations at $58.6M and free cash flow at $23.4M, both up from prior year
- Maintained 411th consecutive quarterly dividend and repurchased ~300k shares
- Cost reduction actions on track to generate $75M in gross savings for 2025
- Higher demand in renewable energy sector for Engineered Bearings segment
- Strong balance sheet position highlighted by management
- Sales declined 4.2% to $1.14B compared to last year
- Net income margin dropped to 6.9% from 8.7% YoY
- Adjusted EBITDA margin decreased to 18.2% from 20.7%
- Diluted EPS fell 24% to $1.11 from $1.46
- Lowered full-year 2025 outlook due to tariff impacts
- Expected $25M negative impact from tariffs in 2025
- Reduced 2025 revenue guidance to -2.5% to 0% compared to 2024
- Lower end-market demand in both business segments
Insights
Timken reports disappointing Q1 results with declining metrics and reduced 2025 outlook due to tariff impacts, despite implementing cost reduction initiatives.
Timken's Q1 2025 results reveal significant pressure across key financial metrics. The company reported
The deterioration in margin performance is particularly noteworthy, with net income margin contracting 180 basis points to
The company has reduced its full-year outlook, now projecting 2025 revenue between
On a positive note, free cash flow improved year-over-year to
- Sales of
, down 4.2 percent from last year$1.14 billion - First-quarter diluted EPS of
; adjusted EPS of$1.11 $1.40 - Updates full-year 2025 outlook to reflect net impact from tariffs; now expects EPS of
, with adjusted EPS of$3.90 -$4.40 $5.10 -$5.60
1Q-25 | 1Q-24 | % Change | |
Net Sales (mils.) | (4.2 %) | ||
Net Income Margin | 6.9 % | 8.7 % | (180 bps) |
Adjusted EBITDA Margin | 18.2 % | 20.7 % | (250 bps) |
Diluted EPS | (24.0 %) | ||
Adjusted EPS | (20.9 %) |
Timken posted net income in the first quarter of
Excluding special items (detailed in the attached tables), adjusted net income in the first quarter was
Net cash provided by operations in the quarter was
"Timken posted solid first-quarter results in a time of heightened uncertainty," said Richard G. Kyle, president and chief executive officer. "Our team executed well in the quarter, delivering on cost actions and other initiatives to help offset the impact of continued soft demand. We remain focused on delivering resilient performance in the face of the international trade challenges that lie ahead."
First-Quarter 2025 Segment Results
Engineered Bearings sales of
Adjusted EBITDA in the quarter was
Industrial Motion sales of
Adjusted EBITDA in the quarter was
2025 Outlook
Timken is reducing its full-year 2025 outlook, with earnings per diluted share now forecasted to be in the range of
The company is now planning for 2025 revenue in the range of -
"We are focused on performing well through this unpredictable business environment," said Kyle. "Our team is moving with urgency to deliver cost savings and is actively implementing pricing and other tactics to mitigate the impact from tariffs. Timken has successfully overcome similar challenges in the past, and we are confident we will navigate the current situation. We have a solid balance sheet, proven strategy and operating model, significant
Conference Call Information
Timken will host a conference call today at 11 a.m. Eastern Time to review its financial results. Presentation materials will be available online in advance of the call for interested investors and securities analysts.
Conference Call: | Wednesday, April 30, 2025 |
11:00 a.m. Eastern Time | |
Live Dial-In: 833-470-1428 | |
Or 404-975-4839 | |
Access Code: 858796 | |
(Call in 10 minutes prior to be included.) | |
Conference Call Replay: | Replay Dial-In available through |
May 14, 2025: | |
866-813-9403 or 929-458-6194 | |
Replay Passcode: 274786 | |
Live Webcast: | |
Register in advance: |
About The Timken Company
The Timken Company (NYSE: TKR; www.timken.com), a global technology leader in engineered bearings and industrial motion, designs a growing portfolio of next-generation products for diverse industries. For more than 125 years, Timken has used its specialized expertise to innovate and create customer-centric solutions that increase reliability and efficiency. Timken posted
Certain statements in this release (including statements regarding the company's forecasts, estimates, plans and expectations) that are not historical in nature are "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. In particular, the statements related to expectations regarding the company's future financial performance, including information under the heading "2025 Outlook," are forward-looking.
The company cautions that actual results may differ materially from those projected or implied in forward-looking statements due to a variety of important factors, including: the finalization of the company's financial statements for the first quarter of 2025; fluctuations in customer demand for the company's products or services; unanticipated changes in business relationships with customers or their purchases from the company; changes in the financial health of the company's customers, which may have an impact on the company's revenues, earnings and impairment charges; logistical issues associated with port closures, delays or increased costs; the impact of changes to the company's accounting methods; political risks associated with government instability; recent world events that have increased the risks posed by international trade disputes, tariffs, sanctions and hostilities; strained geopolitical relations between countries in which we have significant operations; weakness in global or regional general economic conditions and capital markets (as a result of financial stress affecting the banking system or otherwise); changes in wages, shipping costs, raw material costs, energy and fuel prices, and other production costs; changes in costs or customer demand associated with the effects of tariffs; the company's ability to satisfy its obligations under its debt agreements and renew or refinance borrowings on favorable terms; fluctuations in currency valuations or interest rates; changes in the expected costs associated with product warranty claims; the ability to achieve satisfactory operating results in the integration of acquired companies, including realizing any accretion, synergies, and expected cashflow generation within expected timeframes or at all; the company's ability to effectively adjust prices for its products in response to changing dynamics; the impact on the company's pension obligations and assets due to changes in interest rates, investment performance and other tactics designed to reduce risk; the introduction of new disruptive technologies; unplanned plant shutdowns; the effects of government-imposed restrictions, commercial requirements, and company goals associated with climate change and emissions or other sustainability initiatives; unanticipated litigation, claims, investigations remediation, or assessments; the rapidly evolving global regulatory landscape and the corresponding heightened operational complexity and compliance risks; restrictions on the use of, or claims or remediation associated with, per- and polyfluoroalkyl substances or polytetrafluoroethylene; the company's ability to maintain positive relations with unions and works councils; the company's ability to compete for skilled labor and to attract, retain and develop management, other key employees, and skilled personnel; negative impacts to the company's operations or financial position as a result of pandemics, epidemics, or other public health concerns and associated governmental measures; and the company's ability to complete and achieve the benefits of announced plans, programs, initiatives, acquisitions, capital investments, and cost reduction actions. Additional factors are discussed in the company's filings with the Securities and Exchange Commission, including the company's Annual Report on Form 10-K for the year ended Dec. 31, 2024, quarterly reports on Form 10-Q and current reports on Form 8-K. Except as required by the federal securities laws, the company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Media Relations:
Scott Schroeder
234.262.6420
scott.schroeder@timken.com
Investor Relations:
Neil Frohnapple
234.262.2310
neil.frohnapple@timken.com
The Timken Company | ||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | ||||||
(Dollars in millions, except share data) (Unaudited) | ||||||
Three Months Ended | ||||||
2025 | 2024 | |||||
Net sales | $ | 1,140.3 | $ | 1,190.3 | ||
Cost of products sold | 781.6 | 792.7 | ||||
Selling, general & administrative expenses | 184.8 | 190.7 | ||||
Amortization of intangible assets | 19.0 | 20.0 | ||||
Impairment and restructuring charges | 10.9 | 2.3 | ||||
Operating Income | 144.0 | 184.6 | ||||
Non-service pension and other postretirement expense | (1.2) | (1.0) | ||||
Other expense, net | (0.3) | (0.9) | ||||
Interest expense, net | (24.2) | (29.4) | ||||
Income Before Income Taxes | 118.3 | 153.3 | ||||
Provision for income taxes | 26.9 | 42.7 | ||||
Net Income | 91.4 | 110.6 | ||||
Less: Net income attributable to noncontrolling interest | 13.1 | 7.1 | ||||
Net Income Attributable to The Timken Company | $ | 78.3 | $ | 103.5 | ||
Net Income per Common Share Attributable to The Timken Company Common Shareholders | ||||||
Basic Earnings per share | $ | 1.12 | $ | 1.47 | ||
Diluted Earnings per share | $ | 1.11 | $ | 1.46 | ||
Average Shares Outstanding | 70,024,836 | 70,266,660 | ||||
Average Shares Outstanding - assuming dilution | 70,513,937 | 70,880,015 |
BUSINESS SEGMENTS | ||||||
(Unaudited) | ||||||
Three Months Ended | ||||||
(Dollars in millions) | 2025 | 2024 | ||||
Engineered Bearings | ||||||
Net sales | $ | 760.7 | $ | 802.5 | ||
Adjusted Earnings before interest, taxes, depreciation and amortization (EBITDA) (1) | $ | 159.2 | $ | 181.4 | ||
Adjusted EBITDA Margin (1) | 20.9 | % | 22.6 | % | ||
Industrial Motion | ||||||
Net sales | $ | 379.6 | $ | 387.8 | ||
Adjusted Earnings before interest, taxes, depreciation and amortization (EBITDA) (1) | $ | 67.1 | $ | 82.1 | ||
Adjusted EBITDA Margin (1) | 17.7 | % | 21.2 | % | ||
Unallocated corporate expense (1) | $ | (18.2) | $ | (17.1) | ||
Consolidated | ||||||
Net sales | $ | 1,140.3 | $ | 1,190.3 | ||
Adjusted Earnings before interest, taxes, depreciation and amortization (EBITDA) (1) | $ | 208.1 | $ | 246.4 | ||
Adjusted EBITDA Margin (1) | 18.2 | % | 20.7 | % | ||
EBITDA is a non-GAAP measure defined as operating income plus other income (expense) and excluding depreciation and amortization. EBITDA Margin is a non-GAAP measure defined as EBITDA as a percentage of net sales. EBITDA and EBITDA Margin are important financial measures used in the management of the business, including decisions concerning the allocation of resources and assessment of performance. Management believes that reporting EBITDA and EBITDA Margin is useful to investors as these measures are representative of the core operations of the Company. See below for reconciliation of Consolidated EBITDA and Consolidated EBITDA Margin. | ||||||
(1) Consolidated adjusted EBITDA is a non-GAAP measure defined as EBITDA less impairment, restructuring and reorganization charges, acquisition costs, including transaction costs and the amortization of the inventory step-up, actuarial gains and losses associated with the remeasurement of the Company's defined benefit pension and other postretirement benefit plans, property losses and recoveries, gains and losses on the sale of real estate and divestitures, and other items from time to time that are not part of the Company's core operations. Consolidated adjusted EBITDA Margin is a non-GAAP measure defined as Consolidated adjusted EBITDA as a percentage of net sales. Management believes Consolidated adjusted EBITDA and Consolidated adjusted EBITDA Margin are important financial measures used in the management of the business, including decisions concerning the allocation of resources and assessment of performance. Management believes that reporting adjusted EBITDA and adjusted EBITDA Margin is useful to investors as these measures are representative of the core operations of the Company. See below for reconciliation of Consolidated Adjusted EBITDA and Consolidated Adjusted EBITDA Margin. Segment Adjusted EBITDA is the measurement of segment profit and loss. The Company's Chief Operating Decision Maker ("CODM") utilizes Segment Adjusted EBITDA and Segment Adjusted EBITDA Margin to evaluate segment performance and allocates resources. See the Company's Form 10-Q for a reconciliation of Segment Adjusted EBITDA to income before income taxes. |
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||
(Dollars in millions) | (Unaudited) | ||||||
March 31, | December 31, | ||||||
ASSETS | |||||||
Cash and cash equivalents | $ | 376.1 | $ | 373.2 | |||
Restricted cash | 0.4 | 0.4 | |||||
Accounts receivable, net | 744.6 | 664.6 | |||||
Unbilled receivables | 159.0 | 140.8 | |||||
Inventories, net | 1,196.4 | 1,195.6 | |||||
Other current assets | 140.3 | 142.3 | |||||
Total Current Assets | 2,616.8 | 2,516.9 | |||||
Property, plant and equipment, net | 1,317.7 | 1,306.9 | |||||
Operating lease assets | 135.4 | 130.6 | |||||
Goodwill and other intangible assets | 2,428.7 | 2,389.8 | |||||
Other assets | 71.8 | 66.8 | |||||
Total Assets | $ | 6,570.4 | $ | 6,411.0 | |||
LIABILITIES | |||||||
Accounts payable | $ | 338.5 | $ | 321.7 | |||
Short-term debt, including current portion of long-term debt | 21.7 | 13.0 | |||||
Income taxes | 26.0 | 24.4 | |||||
Accrued expenses | 445.5 | 461.4 | |||||
Total Current Liabilities | 831.7 | 820.5 | |||||
Long-term debt | 2,105.4 | 2,049.7 | |||||
Accrued pension benefits | 142.5 | 157.7 | |||||
Accrued postretirement benefits | 29.7 | 29.8 | |||||
Long-term operating lease liabilities | 88.8 | 84.0 | |||||
Other non-current liabilities | 283.3 | 285.2 | |||||
Total Liabilities | 3,481.4 | 3,426.9 | |||||
EQUITY | |||||||
The Timken Company shareholders' equity | 2,917.7 | 2,826.5 | |||||
Noncontrolling interest | 171.3 | 157.6 | |||||
Total Equity | 3,089.0 | 2,984.1 | |||||
Total Liabilities and Equity | $ | 6,570.4 | $ | 6,411.0 | |||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||
(Unaudited) | ||||||
Three Months Ended | ||||||
(Dollars in millions) | 2025 | 2024 | ||||
Cash Provided by (Used in) | ||||||
OPERATING ACTIVITIES | ||||||
Net Income | $ | 91.4 | $ | 110.6 | ||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
Depreciation and amortization | 55.1 | 55.3 | ||||
Stock-based compensation expense | 7.5 | 4.5 | ||||
Pension and other postretirement expense | 1.8 | 1.6 | ||||
Pension and other postretirement benefit contributions and payments | (23.8) | (12.2) | ||||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | (70.8) | (106.1) | ||||
Unbilled receivables | (18.2) | 9.5 | ||||
Inventories | 15.3 | (11.1) | ||||
Accounts payable | 20.2 | 20.7 | ||||
Accrued expenses | (16.0) | (31.2) | ||||
Income taxes | 3.5 | 20.5 | ||||
Other, net | (7.4) | (12.8) | ||||
Net Cash Provided by Operating Activities | $ | 58.6 | $ | 49.3 | ||
INVESTING ACTIVITIES | ||||||
Capital expenditures | $ | (35.2) | $ | (44.1) | ||
Investments in short-term marketable securities, net | 0.8 | 19.7 | ||||
Other, net | 1.9 | (0.1) | ||||
Net Cash Used in Investing Activities | $ | (32.5) | $ | (24.5) | ||
FINANCING ACTIVITIES | ||||||
Cash dividends paid to shareholders | $ | (25.1) | $ | (24.5) | ||
Purchase of treasury shares | (23.1) | — | ||||
Proceeds from exercise of stock options | 0.3 | 2.0 | ||||
Payments related to tax withholding for stock-based compensation | (9.5) | (8.9) | ||||
Net proceeds from credit facilities | 28.0 | 17.7 | ||||
Net payments on long-term debt | (1.2) | (1.3) | ||||
Net Cash Used in Financing Activities | $ | (30.6) | $ | (15.0) | ||
Effect of exchange rate changes on cash | 7.4 | (6.8) | ||||
Increase in Cash, Cash Equivalents and Restricted Cash | $ | 2.9 | $ | 3.0 | ||
Cash, Cash Equivalents and Restricted Cash at Beginning of Period | 373.6 | 419.3 | ||||
Cash, Cash Equivalents and Restricted Cash at End of Period | $ | 376.5 | $ | 422.3 |
Reconciliations of Adjusted Net Income to GAAP Net Income and Adjusted Earnings Per Share to GAAP Earnings Per Share: | ||||||||||||||
(Unaudited) | ||||||||||||||
The following reconciliation is provided as additional relevant information about the Company's performance deemed useful to investors. Management believes that the non-GAAP measures of adjusted net income and adjusted diluted earnings per share are important financial measures used in the management of the business, including decisions concerning the allocation of resources and assessment of performance. Management believes that reporting adjusted net income and adjusted diluted earnings per share is useful to investors as these measures are representative of the Company's core operations. | ||||||||||||||
(Dollars in millions, except share data) | Three Months Ended | |||||||||||||
2025 | EPS | 2024 | EPS | |||||||||||
Net Income Attributable to The Timken Company | $ | 78.3 | $ | 1.11 | $ | 103.5 | $ | 1.46 | ||||||
Adjustments: (1) | ||||||||||||||
Acquisition intangible amortization | $ | 19.0 | $ | 20.0 | ||||||||||
Impairment, restructuring and reorganization charges (2) | 3.2 | 4.8 | ||||||||||||
Acquisition-related charges (3) | — | 4.7 | ||||||||||||
Gain on sale of certain assets (4) | (1.2) | (0.7) | ||||||||||||
CEO succession expenses (5) | 8.6 | — | ||||||||||||
Noncontrolling interest of above adjustments (6) | 3.8 | (0.1) | ||||||||||||
Provision for income taxes (7) | (13.1) | (6.5) | ||||||||||||
Total Adjustments: | 20.3 | 0.29 | 22.2 | 0.31 | ||||||||||
Adjusted Net Income Attributable to The Timken Company | $ | 98.6 | $ | 1.40 | $ | 125.7 | $ | 1.77 | ||||||
(1) Adjustments are pre-tax, with the net tax provision listed separately. | ||||||||||||||
(2) Impairment, restructuring and reorganization charges (including items recorded in cost of products sold) relate to: (i) plant closures; (ii) the rationalization of certain plants; (iii) severance related to cost reduction initiatives; (iv) impairment of assets; and (v) related depreciation and amortization. The Company re-assesses its operating footprint and cost structure periodically, and makes adjustments as needed that result in restructuring charges. However, management believes these actions are not representative of the Company's core operations. | ||||||||||||||
(3) Acquisition-related charges represent deal-related expenses associated with completed transactions and any resulting inventory step-up impact. | ||||||||||||||
(4) Represents the net gain resulting from the sale of certain assets. | ||||||||||||||
(5) On March 31, 2025, the Company announced that Tarak B. Mehta, President and Chief Executive Officer ("CEO") of the Company would be departing from the Company, effective immediately, and Richard G. Kyle will be serving as interim President and CEO. CEO succession expenses primarily relate to the cost of the settlement agreement with Mr. Mehta in connection with his departure, net of stock compensation expense for stock awards forfeited. During 2024, the Company announced that Mr. Kyle, President and CEO of the Company would be retiring from his position as CEO as of February 15, 2025 and that Mr. Mehta would be appointed CEO on September 5, 2024. CEO succession expenses also include the acceleration of certain stock compensation awards for Mr. Kyle and other one-time costs associated with the transition in 2024. | ||||||||||||||
(6) Represents the noncontrolling interest impact of the adjustments listed above, as well as the reversal of uncertain tax positions related to Timken India Limited. | ||||||||||||||
(7) Provision for income taxes includes the net tax impact on pre-tax adjustments (listed above), the impact of discrete tax items recorded during the respective periods as well as other adjustments to reflect the use of one overall effective tax rate on adjusted pre-tax income in interim periods. | ||||||||||||||
Reconciliation of EBITDA to GAAP Net Income, EBITDA Margin to Net Income as a Percentage of Sales, and EBITDA Margin, After Adjustments, to Net Income as a Percentage of Sales, and EBITDA, After Adjustments, to Net Income: | ||||||||||
(Unaudited) | ||||||||||
The following reconciliation is provided as additional relevant information about the Company's performance deemed useful to investors. Management believes consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) is a non-GAAP measure that is useful to investors as it is representative of the Company's performance and that it is appropriate to compare GAAP net income to consolidated EBITDA. Management also believes that adjusted EBITDA, adjusted EBITDA margin and EBITDA margin are useful to investors as they are representative of the Company's core operations and are used in the management of the business, including decisions concerning the allocation of resources and assessment of performance. | ||||||||||
(Dollars in millions) | Three Months Ended | |||||||||
2025 | Percentage to | 2024 | Percentage to | |||||||
Net Income | $ | 91.4 | 8.0 | % | $ | 110.6 | 9.3 | % | ||
Provision for income taxes | 26.9 | 42.7 | ||||||||
Interest expense | 26.5 | 32.2 | ||||||||
Interest income | (2.3) | (2.8) | ||||||||
Depreciation and amortization | 55.1 | 55.3 | ||||||||
Consolidated EBITDA | $ | 197.6 | 17.3 | % | $ | 238.0 | 20.0 | % | ||
Adjustments: | ||||||||||
Impairment, restructuring and reorganization charges (1) | $ | 3.1 | $ | 4.4 | ||||||
Acquisition-related charges (2) | — | 4.7 | ||||||||
Gain on sale of certain assets (3) | (1.2) | (0.7) | ||||||||
CEO succession expenses (4) | 8.6 | — | ||||||||
Total Adjustments | 10.5 | 0.9 | % | 8.4 | 0.7 | % | ||||
Adjusted EBITDA | $ | 208.1 | 18.2 | % | $ | 246.4 | 20.7 | % | ||
(1) Impairment, restructuring and reorganization charges (including items recorded in cost of products sold) relate to: (i) plant closures; (ii) the rationalization of certain plants; (iii) severance related to cost reduction initiatives; and (iv) impairment of assets. The Company re-assesses its operating footprint and cost structure periodically, and makes adjustments as needed that result in restructuring charges. However, management believes these actions are not representative of the Company's core operations. | ||||||||||
(2) Acquisition-related charges represent deal-related expenses associated with completed transactions and any resulting inventory step-up impact. | ||||||||||
(3) Represents the net gain resulting from sale of certain assets. | ||||||||||
(4) On March 31, 2025, the Company announced that Tarak B. Mehta, President and CEO of the Company would be departing from the Company, effective immediately, and Richard G. Kyle will be serving as interim President and CEO. CEO succession expenses primarily relate to the cost of the settlement agreement with Mr. Mehta in connection with his departure, net of stock compensation expense for stock awards forfeited. During 2024, the Company announced that Mr. Kyle, President and CEO of the Company would be retiring from his position as CEO as of February 15, 2025 and that Mr. Mehta would be appointed CEO on September 5, 2024. CEO succession expenses also include the acceleration of certain stock compensation awards for Mr. Kyle and other one-time costs associated with the transition in 2024. | ||||||||||
Reconciliation of Total Debt to Net Debt, the Ratio of Net Debt to Capital, and the Ratio of Net Debt to Adjusted EBITDA: | ||||||
(Unaudited) | ||||||
These reconciliations are provided as additional relevant information about the Company's financial position deemed useful to investors. Capital, used for the ratio of net debt to capital, is a non-GAAP measure defined as total debt less cash and cash equivalents plus total shareholders' equity. Management believes Net Debt, the Ratio of Net Debt to Capital, Adjusted EBITDA (see next page), and the Ratio of Net Debt to Adjusted EBITDA are important measures of the Company's financial position, due to the amount of cash and cash equivalents on hand. The Company presents net debt to adjusted EBITDA because it believes it is more representative of the Company's financial position as it is reflective of the ability to cover its net debt obligations with results from its core operations. | ||||||
(Dollars in millions) | ||||||
March 31, | December 31, | |||||
Short-term debt, including current portion of long-term debt | $ | 21.7 | $ | 13.0 | ||
Long-term debt | 2,105.4 | 2,049.7 | ||||
Total Debt | $ | 2,127.1 | $ | 2,062.7 | ||
Less: Cash and cash equivalents | (376.1) | (373.2) | ||||
Net Debt | $ | 1,751.0 | $ | 1,689.5 | ||
Total Equity | $ | 3,089.0 | $ | 2,984.1 | ||
Ratio of Net Debt to Capital | 36.2 | % | 36.1 | % | ||
Adjusted EBITDA for the Twelve Months Ended | $ | 806.5 | $ | 844.8 | ||
Ratio of Net Debt to Adjusted EBITDA | 2.2 | 2.0 | ||||
Reconciliation of Free Cash Flow to GAAP Net Cash Provided by Operating Activities: | ||||||
(Unaudited) | ||||||
Management believes that free cash flow is a non-GAAP measure that is useful to investors because it is a meaningful indicator of cash generated from operating activities available for the execution of its business strategy. | ||||||
(Dollars in millions) | ||||||
Three Months Ended | ||||||
2025 | 2024 | |||||
Net cash provided by operating activities | $ | 58.6 | $ | 49.3 | ||
Less: capital expenditures | (35.2) | (44.1) | ||||
Free cash flow | $ | 23.4 | $ | 5.2 |
Reconciliation of EBITDA, After Adjustments, to GAAP Net Income: | ||||||
(Unaudited) | ||||||
The following reconciliation is provided as additional relevant information about the Company's performance deemed useful to investors. Management believes consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) is a non-GAAP measure that is useful to investors as it is representative of the Company's performance and that it is appropriate to compare GAAP net income to consolidated EBITDA. Management also believes that the non-GAAP measure of adjusted EBITDA is useful to investors as it is representative of the Company's core operations and is used in the management of the business, including decisions concerning the allocation of resources and assessment of performance. | ||||||
(Dollars in millions) | Twelve Months Ended | Twelve Months Ended | ||||
Net Income | $ | 356.1 | $ | 375.3 | ||
Provision for income taxes | 103.1 | 118.9 | ||||
Interest expense | 119.4 | 125.1 | ||||
Interest income | (14.4) | (14.9) | ||||
Depreciation and amortization | 221.6 | 221.8 | ||||
Consolidated EBITDA | $ | 785.8 | $ | 826.2 | ||
Adjustments: | ||||||
Impairment, restructuring and reorganization charges (1) | $ | 16.5 | $ | 17.8 | ||
Corporate pension and other postretirement benefit related income (2) | (1.3) | (1.3) | ||||
Acquisition-related charges (3) | 8.3 | 13.0 | ||||
Gain on sale of certain assets (4) | (15.2) | (14.7) | ||||
Property losses and related expenses (5) | 1.2 | 1.2 | ||||
CEO succession expenses (6) | 12.3 | 3.7 | ||||
Tax indemnification and related items | (1.1) | (1.1) | ||||
Total Adjustments | 20.7 | 18.6 | ||||
Adjusted EBITDA | $ | 806.5 | $ | 844.8 | ||
(1) Impairment, restructuring and reorganization charges (including items recorded in cost of products sold) relate to: (i) plant closures; (ii) the rationalization of certain plants; (iii) severance related to cost reduction initiatives; and (iv) impairment of assets. The Company re-assesses its operating footprint and cost structure periodically, and makes adjustments as needed that result in restructuring charges. However, management believes these actions are not representative of the Company's core operations. | ||||||
(2) Corporate pension and other postretirement benefit related income represents actuarial gains that resulted from the remeasurement of plan assets and obligations as a result of changes in assumptions or experience. The Company recognizes actuarial gains and losses in connection with the annual remeasurement in the fourth quarter, or if specific events trigger a remeasurement. | ||||||
(3) Acquisition-related charges represent deal-related expenses associated with completed transactions and any resulting inventory step-up impact. | ||||||
(4) Represents the net gain resulting from sale of certain assets. Gain on sale of certain assets for the third quarter of 2024 included | ||||||
(5) Represents property loss and related expenses incurred during the periods presented resulting from property loss that occurred during the second quarter of 2024 at one of the Company's plants in | ||||||
(6) On March 31, 2025, the Company announced that Tarak B. Mehta, President and CEO of the Company would be departing from the Company, effective immediately, and Richard G. Kyle will be serving as interim President and CEO. During 2024, the Company announced that Mr. Kyle, President and CEO of the Company would be retiring from his position as CEO as of February 15, 2025 and that Mr. Mehta would be appointed CEO on September 5, 2024. CEO succession expenses for the twelve months ended March 31, 2025 relate to the cost of the settlement agreement with Mr. Mehta in connection with his departure, net of stock compensation expense for stock awards forfeited, plus the acceleration of certain stock compensation awards for Mr. Kyle in connection with his retirement, and other one-time costs associated with the transition in 2024. |
Reconciliation of Net Sales to Organic Sales | |||||||||||||
(Unaudited) | |||||||||||||
The following reconciliation is provided as additional relevant information about the Company's performance deemed useful to investors. Management believes that net sales, excluding the impact of acquisitions, divestitures and foreign currency exchange rate changes, allow investors and the Company to meaningfully evaluate the percentage change in net sales on a comparable basis from period to period. | |||||||||||||
Three Months Ended | Three Months Ended | $ Change | % Change | ||||||||||
Net sales | $ | 1,140.3 | $ | 1,190.3 | $ | (50.0) | (4.2) | % | |||||
Less: Acquisitions | 12.3 | — | 12.3 | NM | |||||||||
Currency | (25.1) | — | (25.1) | NM | |||||||||
Net sales, excluding the impact of acquisitions and currency | $ | 1,153.1 | $ | 1,190.3 | $ | (37.2) | (3.1) | % | |||||
Reconciliation of Adjusted Earnings per Share to GAAP Earnings per Share for Full Year 2025 Outlook: | |||||||
(Unaudited) | |||||||
The following reconciliation is provided as additional relevant information about the Company's outlook deemed useful to investors. Forecasted full year adjusted diluted earnings per share is an important financial measure that management believes is useful to investors as it is representative of the Company's expectation for the performance of its core business operations. | |||||||
Low End Earnings | High End Earnings | ||||||
Forecasted full year GAAP diluted earnings per share | $ | 3.90 | $ | 4.40 | |||
Forecasted Adjustments: | |||||||
Impairment, restructuring and other special items, net (1) | 0.40 | 0.40 | |||||
Acquisition-related intangible amortization expense, net | 0.80 | 0.80 | |||||
Forecasted full year adjusted diluted earnings per share | $ | 5.10 | $ | 5.60 | |||
(1) Impairment, restructuring and other special items, net do not include the impact of any potential future mark-to-market pension and other postretirement remeasurement adjustments, because the amounts will not be known until incurred. | |||||||
View original content to download multimedia:https://www.prnewswire.com/news-releases/timken-reports-first-quarter-2025-results-302441799.html
SOURCE The Timken Company